Ekso Bionics Holdings Inc
NASDAQ:EKSO
Ekso Bionics Holdings Inc
Cash from Financing Activities
Ekso Bionics Holdings Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
Cash from Financing Activities
$348k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Ekso Bionics Holdings Inc's Cash from Financing Activities?
Cash from Financing Activities
348k
USD
Based on the financial report for Dec 31, 2023, Ekso Bionics Holdings Inc's Cash from Financing Activities amounts to 348k USD.
What is Ekso Bionics Holdings Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-31%
The average annual Cash from Financing Activities growth rates for Ekso Bionics Holdings Inc have been -68% over the past three years , -31% over the past five years .